Printer Friendly

SEISMED INSTRUMENTS ANNOUNCES EXCEPTION EXTENSION FROM NASDAQ REQUIREMENTS AND ACCEPTANCE OF MULTICENTER STUDY FOR PUBLICATION

SEISMED INSTRUMENTS ANNOUNCES EXCEPTION EXTENSION FROM NASDAQ REQUIREMENTS
 AND ACCEPTANCE OF MULTICENTER STUDY FOR PUBLICATION
 MINNEAPOLIS, Sept. 30 /PRNewswire/ -- Seismed Instruments Incorporated (NASDAQ: SEISC) announced today that its common stock will continue to be listed on the NASDAQ Small-Cap Market System via an exception from the minimum total asset and capital and surplus requirements.
 While Seismed Instruments failed to meet these requirements as of March 31, 1992, it was granted two previous temporary exemptions until Aug. 15, 1992, and Sept. 15, 1992, from these requirements subject to meeting certain conditions. On Sept. 22, 1992, the company was granted an extension of the temporary exception until Nov. 15, 1992. The company continues to pursue the sale of equity through a public offering of common stock. If the company successfully completes this offering, it will be able to meet the NASDAQ minimum total assets and capital and surplus requirements. If, at some future date, the company's common stock should cease to be listed on the NASDAQ Small-Cap Market, it may continue to be listed on the NASDAQ OTC-Bulletin Board. For the duration of the exception, the company's NASDAQ symbol will be SEISC.
 The company also announced that the Multicenter Clinical Study sponsored by the company and conducted by independent clinical investigators has now been accepted for publication in The American Journal of Cardiology. The acceptance of the manuscript for publication culminates a three-year effort which began with the enrollment of the first patients in the study in September 1989. Over 660 patients were enrolled in the study at the five participating centers which included Oregon Health Sciences University, Portland, Ore.; Medical College of Wisconsin, Milwaukee; Washington Hospital Center, Washington, D.C.; University of Michigan, Ann Arbor, Mich.; and The Graduate Hospital, Philadelphia. The results of the Multicenter Study confirm the findings of the first major clinical study on exercise seismocardiography (SCG) which was conducted at the Minneapolis Heart Institute on over 1,200 patients and will soon be published in the American Journal of Noninvasive Cardiology. Exercise SCG improves the accuracy of the diagnosis of coronary artery disease when used in conjunction with routine stress electrocardiography (ECG) testing.
 Seismed Instruments develops, produces and markets proprietary cardiology instrumentation and software based digital signal processed accelerometry technology. The company's SCG-2000 is an instrument used in conjunction with routine stress ECG testing to noninvasively diagnose coronary artery disease.
 -0- 09/30/92
 CONTACT: Sandra J. Garlough, president ?chief executive officer of Seismed Instruments, 612-473-5151
 (SEISC) CO: SEISMED INSTRUMENTS INCORPORATED IN: MTC ST: MN -- MN012 -- X644 09/30/92
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 30, 1992
Words:423
Previous Article:SEVERN TRENT WINS LONG ISLAND CONTRACT
Next Article:BOB EVANS FARM FESTIVAL IS JUST AROUND THE CORNER
Topics:


Related Articles
SEISMED INSTRUMENTS ELECTS NEW BOARD MEMBER
SEISMED INSTRUMENTS ANNOUNCES RESULTS
SEISMED INSTRUMENTS RECEIVES FDA CLEARANCE TO MARKET NEW INTERPRETATION SOFTWARE
SEISMED INSTRUMENTS FILES FOR OFFERING OF COMMON STOCK
SEISMED INSTRUMENTS INC STOCKS WILL CONTINUE TO BE LISTED ON THE NASDAQ SMALL-CAP MARKET SYSTEM
SEISMED INSTRUMENTS REPORTS THIRD QUARTER RESULTS
SEISMED INSTRUMENTS INCORPORATED STOCK WILL CONTINUE TO BE LISTED ON NASDAQ SMALL-CAP MARKET SYSTEM
SEISMED INSTRUMENTS COMPLETES OFFERING AND PUBLICATION OF CLINICAL RESULTS
SEISMED INSTRUMENTS ANNOUNCES FIRST QUARTER RESULTS
SEISMED INSTRUMENTS APPOINTS NEW CHIEF EXECUTIVE OFFICER

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters